Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models-Reference-Cited by-同舟云学术

Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models

Published:2016-09 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Shen Xiujin,Jiang Hong,Ying Meike,Xie Zhoutao,Li Xiayu,Wang Haibing,Zhao Jie,Lin Chuan,Wang Yucheng,Feng Shi,Shen Jia,Weng Chunhua,Lin Weiqiang,Wang Huiping,Zhou Qin,Bi Yan,Li Meng,Wang Lingyan,Zhu Tongyu,Huang Xiaoru,Lan Hui-Yao,Zhou Jing,Chen Jianghua

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep32087.pdf

Reference54 articles.

1. Mathieson, P. W. The podocyte as a target for therapies–new and old. NATURE REVIEWS NEPHROLOGY 8, 52–56 (2011).

2. Welsh G. I. & S. M. The podocyte cytoskeleton–key to a functioning glomerulus in health and disease. Nat Rev Nephrol 8, 14–21 (2011).

3. Hogan, J. & Radhakrishnan, J. The treatment of minimal change disease in adults. J Am Soc Nephrol 24, 702–711, doi: 10.1681/asn.2012070734 (2013).

4. Peng, L. et al. The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4. PloS one 9, e106164, doi: 10.1371/journal.pone.0106164 (2014).

5. Stefanidis, C. J. & Querfeld, U. The podocyte as a target: cyclosporin A in the management of the nephrotic syndrome caused by WT1 mutations. Eur J Pediatr 170, 1377–1383, doi: 10.1007/s00431-011-1397-6 (2011).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study;Frontiers in Pharmacology;2024-09-03

2. Enhanced IGF‐IIRα Expression Exacerbates Lipopolysaccharide‐Induced Cardiac Inflammation, Hypertrophy, and Apoptosis Through Calcineurin Activation;Environmental Toxicology;2024-08-07

3. Podocyte-targeted therapies — progress and future directions;Nature Reviews Nephrology;2024-05-09

4. Mechanism of tacrolimus in the treatment of lupus nephritis;Frontiers in Pharmacology;2024-05-07

5. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study;International Urology and Nephrology;2024-04-20